Treatment.com AI Inc. (TREIF)
| Previous Close | 0.5886 |
| Open | 0.5886 |
| Bid | 0.5554 x 0 |
| Ask | 0.5823 x 0 |
| Day's Range | 0.5886 - 0.5886 |
| 52 Week Range | 0.0471 - 0.9116 |
| Volume | |
| Avg. Volume | 24,306 |
| Market Cap | 22.511M |
| Beta (5Y Monthly) | -0.52 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1600 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GlobeNewswireRepeat: Treatment.com AI Provides an Update on the Status of Exercised Warrants
●~800,000 warrants exercised since free trading was announced raising close to half a million dollars. ●Remaining warrants could bring over $2 million in additional funds. ●Robust acquisition pipeline VANCOUVER, British Columbia, July 24, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”), a healthcare tech company transforming patient care with AI-driven clinical insights is pleased to provide the market with an update on the ex
- GlobeNewswire
Treatment.com AI Provides an Update on the Status of Exercised Warrants
●~800,000 warrants exercised since free trading was announced raising close to half a million dollars. ●Remaining warrants could bring over $2 million in additional funds. ●Robust acquisition pipeline VANCOUVER, British Columbia, July 24, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”), a healthcare tech company transforming patient care with AI-driven clinical insights is pleased to provide the market with an update on the ex
- GlobeNewswire
Repeat: Treatment.com AI Provides Latest Corporate Update
●Positive Financial Update ●New Partnerships Announced - aiXplain/Novus Health ●GLM - AI Accuracy and Effectiveness in Healthcare ●Bolstering the Executive, Scientific and Development Team - Dr. Jean Challiner ●AI Patient and AI Doctor in Your Pocket planned release in H2 VANCOUVER, British Columbia, July 09, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment AI”) is pleased to provide a general corporate update. Treatment AI has b
